C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 403/04 (2006.01) A61K 31/506 (2006.01) A61K 31/5377 (2006.01) A61P 35/00 (2006.01) C07D 401/14 (2006.01) C07D 413/14 (2006.01)
Patent
CA 2589793
Compounds of the formula: (I): wherein variable groups are as defined within and a pharmaceutically acceptable salts and in vivo hydrolysable esters are described. Also described are processes for their preparation and their use as medicaments, particularly medicaments for producing a cell cycle inhibitory (anti-cell-proliferation) effect in a warm-blooded animal, such as man.
La présente invention concerne des composés de formule : (I): dans laquelle des groupes variables sont tels que définis dans la description ; l~invention décrit des sels pharmaceutiquement acceptables et des esters hydrolysables in vivo . L~invention décrit également des procédés pour leur préparation et leur utilisation en tant que médicaments, en particulier des médicaments destinés à induire un effet d~inhibition du cycle cellulaire (anti-prolifération cellulaire) chez un animal à sang chaud, tel que l~être humain.
Andrews David
Finlay Maurice Raymond
Green Clive
Jones Clifford
Astrazeneca Ab
Fetherstonhaugh & Co.
LandOfFree
4-(4-(imidazol-4-yl)pyrimidin-2-ylamino) benzamides as cdk... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-(4-(imidazol-4-yl)pyrimidin-2-ylamino) benzamides as cdk..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-(4-(imidazol-4-yl)pyrimidin-2-ylamino) benzamides as cdk... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1941265